One of the major reasons why the Serum Institute of India could launch their Covid-19 vaccine quickly was due to forthcoming grants, permission, encouragement to industries and considerably reduced licensing raj, Cyrus Poonawalla, MD and Chairman of SII, said on Friday.

“We have a Drug Controller who responds even after office hours,” the Serum Institute Chairman said at the Tilak Maharashtra Vidyapeeth in Pune.

Cyrus Poonawalla also reportedly said that he is opposed to the mixing of Covishield and Covaxin that is currently under proposal.

Subscribe to Mint Newsletters

* Enter a valid email

* Thank you for subscribing to our newsletter.

Never miss a story! Stay connected and informed with Mint.
Download
our App Now!!



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here